NHIA applauds the guidance issued by FDA to allow for decentralized clinical trials, including in patients’ homes. NHIA believes that allowing decentralized clinical trials will improve the representation in trials. According to the FDA guidance, “remote clinical trial visits and…
Support NHIF and Infuse Wellness this October into your life and others. There are many ways to participate—get together with your colleagues and form a team to compete against the NHIA staff and other members.
Rep. Earl L. “Buddy” Carter (R-GA.), one of two pharmacists in Congress, penned an op-ed, "Four years later, Medicare policy is still failing home infusion therapy patients" recently published in The Hill. The article highlights flaws in CMS’ implementation of…